From Wikipedia, the free encyclopedia
Jump to: navigation, search
MDG Brand RGB.jpg
Medigene AG
Stock company
Traded as MDG1
Industry Biotechnology
Founded 1994
Headquarters Martinsried, Germany
Key people
Prof Dolores J Schendel (CEO), Dave Lemus (COO), Horst Domdey (Chairman of the supervisory board)

Medigene AG is a publicly listed (Frankfurt: MDG1, prime standard) biotechnology company headquartered in Martinsried near Munich, Germany. The company is developing highly innovative, complementary treatment platforms to target various types and stages of cancer with candidates in clinical and pre-clinical development. Medigene concentrates on the development of personalized T cell-based immunotherapies.

For more information, please visit


External links[edit]